MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, IMDX has $40,427K in assets. $51,118K in debts. $28,201K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
254.20%
Quick Ratio
251.02%
Cash Ratio
234.91%
Debt to Asset Ratio
126.45%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Machinery and equipment, net, an...
    • Right-of-use operating and finan...
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Common stock, no par value, 230,...
    • Contingent consideration liabili...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
28,201 11,583 18,692 24,287
Accounts receivable, net of allowance for credit losses of 2 and 11, respectively
157 1,128 258 512
Inventories
382 446 471 693
Deferred financing costs
-0 --
Intangible assets, net
-0 14,600 14,600
Restricted cash, current
729 729 729 -
Prepaid expenses and other current assets
1,048 1,420 1,239 1,350
Total current assets
30,517 15,306 21,389 26,842
Right-of-use and financing lease assets, net
--2,340 2,524
Right-of-use operating and financing lease assets, net
2,459 2,815 --
Machinery and equipment, net, and construction in progress
6,452 6,435 4,147 4,149
Restricted cash, noncurrent
425 607 789 1,700
Other noncurrent assets
574 593 672 702
Total assets
40,427 25,756 43,937 50,517
Accounts payable
1,615 2,544 1,056 1,277
Due to related party (note 9)
2,736 2,780 --
Accrued compensation
3,333 2,461 2,228 1,459
Accrued royalties
1,116 1,116 1,120 1,116
Accrued expenses and other current liabilities
1,284 939 602 571
Right-of-use and financing lease liabilities, current
--1,598 1,540
Operating and financing lease liabilities, current
1,762 1,807 --
Contingent consideration liabilities, current
159 428 1,056 689
Total current liabilities
12,005 12,075 7,660 6,652
Right-of-use and financing lease liabilities, noncurrent
--1,529 1,834
Operating and financing lease liabilities, noncurrent
1,307 1,690 --
Contingent consideration liabilities, noncurrent
37,806 43,455 43,944 40,933
Total liabilities
51,118 57,220 53,133 49,419
Preferred stock, no par value, 5,000 shares authorized no shares issued and outstanding
0 0 -0
Common stock, no par value, 230,000 shares authorized 32,286 and 28,683 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively
394,289 369,211 368,524 367,965
Accumulated other comprehensive income
71 86 86 85
Accumulated deficit
-405,051 -400,761 -377,806 -366,952
Total shareholders' deficit
-10,691 -31,464 -9,196 1,098
Total liabilities and shareholders' deficit
40,427 25,756 43,937 50,517
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$28,201K Prepaid expenses andother current assets$1,048K Restricted cash, current$729K Inventories$382K Accounts receivable, netof allowance for...$157K Total current assets$30,517K Machinery and equipment,net, and...$6,452K Right-of-use operating andfinancing lease assets,...$2,459K Other noncurrentassets$574K Restricted cash,noncurrent$425K Total assets$40,427K Accumulated deficit-$405,051K Total liabilities andshareholders' deficit$40,427K Total shareholders'deficit-$10,691K Common stock, no parvalue, 230,000 shares...$394,289K Accumulated othercomprehensive income$71K Total liabilities$51,118K Contingent considerationliabilities, noncurrent$37,806K Total currentliabilities$12,005K Operating and financinglease liabilities,...$1,307K Accrued compensation$3,333K Due to related party(note 9)$2,736K Operating and financinglease liabilities,...$1,762K Accounts payable$1,615K Accrued expenses andother current...$1,284K Accrued royalties$1,116K Contingent considerationliabilities, current$159K

Insight Molecular Diagnostics Inc. (IMDX)

Insight Molecular Diagnostics Inc. (IMDX)